Agenda

Session I - Electrophysiology During COVID

8:00 – 8:10
Heart Rhythm Society – Navigating a Global Pandemic and Serving the Needs of the Members

8:10 – 8:20
The Big Bold Vision for Electrophysiology – The HRS Perspective

8:20 – 8:30
COVID-Related Cardiac Arrhythmias and Myocarditis – Diagnosis, Management, and Risk Stratification

8:30 – 8:40
Did COVID Impact the Practice of Electrophysiology? The Good, the Bad and the Ugly

8:40 – 9:00
Panel Discussion

Session II - Pioneer Award Celebration

9:00 – 9:30
Pioneer in Cardiovascular Electrophysiology Award Presentation - Keynote Speaker

9:30 – 9:40
What all Did We Learn from CABANA, EAST AF NET, and EARLY AF?

Session III - Thinking Outside the Box for Heart Failure

9:40 – 9:50
Role of Cardiac Contractility and Vagal Nerve Stimulation in Managing Patients with Heart Failure

9:50 – 10:00
The AF-HFpEF Syndrome – Role of Rhythm Control Through Catheter Ablation

10:00 – 10:10
Leadless Left Ventricular Pacing Using Transthoracic Ultrasound Stimulation

10:10 – 10:20
Advances in His Bundle Pacing and Left Bundle Pacing – Tools, Techniques, and Data

10:20 – 10:40
Panel Discussion

Session IV - Prevention and Management of Cardiac Device Infection

10:40 – 10:50
What Are the Barriers to the Identification and Management of Cardiac Device-Related Infections?

10:50 – 11:00
Role of Antibiotic Prophylaxis, Pouches, Rinses, and Other Techniques in Preventing CIED Infections

11:00 – 11:10
Bacteremia and CIED – How Do You Manage an Infected CIED?

11:10 – 11:20
Latest in Tools and Techniques for Extraction of Cardiac Devices

11:20 – 11:40
Panel Discussion

11:40 – 12:00
Break

12:00 – 1:00
Lunch
12:00 – 1:00
Non-CME Session Town Hall Meeting – To be held in a separate area
Staying Ahead: Innovation, Safety, Reimbursement, and Cost-Containment Through Committed Partnership

Participants: CMOs or CEOs of AtriCure, Medtronic, Abbott EP, Boston Scientific, Biosense Webster, Biotronik, Phillips, and Acutus

Session V – Innovations in AF Management

1:00 – 1:10
Role of Rapid Non-Contact Mapping in Understanding and Treating Atrial Arrhythmia

1:10 – 1:20
Insights into Atrial Substrate Through Rapid Multi-Polar Mapping Technologies – A Recipe for Enhanced Success

1:20 – 1:50
What Is the Best Mapping and Ablation Approach for Long-Standing Persistent AF? Cooking the Atrium in 3 Different Ways

1:50 – 2:10
Panel Discussion

Session VI –What is the Buzz About Pulse Field Ablation?

2:10 – 2:20
How Exactly Is Pulse Field Ablation Different from Radiofrequency Ablation?

2:20 – 2:30
What Have We Learned About the Therapeutic Efficacy of PFA in AF?

2:30 – 2:40
Can PFA Deliver on the High Promises of Safety – Hope or Hype?

2:40 – 2:50
Novel Technologies in PFA

2:50 – 3:00
What Data Need to Be Generated for PFA to Be Primetime?

3:10 – 3:20
Break

Session VII – Improving the Efficiency of Ablation

3:20 – 3:30
Catheter Tip Modification and Impact on Procedural Outcomes

3:30 – 3:40
The Science Behind the Indices of Ablation – Ablation Index, Lesion Stability Index, and More

3:40 – 3:50
Left Atrial Scar and Ablation Strategy – Personalized Approach in AF Ablation

3:50 – 4:00
Behavioral Modification in Improving Risk Factors in AF Patients – Role of Lifestyle Medicine

4:00 – 4:10
Hybrid Ablation – Who and When

4:10 – 4:20
Role of IV Sotalol in Clinical EP Practice

4:20 – 4:30
Panel Discussion

Session VIII – Myocardial Inflammation and Electrophysiology

4:30 – 4:40
Myocarditis, Arrhythmias, and Sudden Cardiac Death – Understanding the Connection

4:40 – 4:50
Non-Ischemic Cardiomyopathy and Myocardial Inflammation – An Evolving Paradigm

4:50 – 5:00
Diagnostic and Management Strategies for Arrhythmogenic Myocarditis

5:00 – 5:10
Risk Stratification for SCD in Patients with Infiltrative and Inflammatory Cardiomyopathies

5:10 – 5:20 Role of Pacing Therapies in Treating Central and Obstructive Sleep Apnea

5:20 – 5:30
Panel Discussion

Session IX - Stroke Prophylaxis

8:00 – 8:10
What Did We Learn from LAAOS-3? Role of LAA Exclusion in Stroke Prophylaxis

8:10 – 8:20
Stroke Prophylaxis and LAA Endocardial Occluders – Where Are We Today?

8:20 – 8:30
Role of LAA in Arrhythmogenesis, and Management Strategies and Pitfalls

8:30 – 8:40
LAA Closure After Successful AF Ablation – Can It Mitigate the Need for Continued Oral Anticoagulation?

8:40 – 8:50
Closure Options for Unusual LAA Anatomies

8:50 – 9:00
Panel Discussion

Session X - Digital Health in Electrophysiology

9:00 – 9: 10
Define AF – Managing AF Through Implantable Cardiac Monitors in the Digital Playground

9:10 – 9:20
Smart Watches and Wearable External Heart Rhythm Monitors – Where Do They Fit in the EP Practice?
9:20 – 9:30
Machine Learning in Optimizing Electrophysiology Procedures – How far Have We Come?

9:30 – 9:40
Digital Health Tools That Can Optimize the Care of Patients in the Outpatient Setting

9:40 – 10:00
Panel Discussion

10:00 – 10:10
Break

Session XI - Managing Ventricular Arrhythmias

10:10 – 10:20
What Is the Most Practical Approach to Performing VT Ablation?

10:20 – 10:30
Role of Remote Magnetic Navigation in VT Ablation

10:30 – 10:40
What is the Role of a Wearable External Defibrillator in Primary and Secondary Prevention of SCD

10:40 – 10:50
How to Improve Success Rates of a Summit and Papillary Muscle PVC Ablation

10:50 – 11:10
Panel Discussion

Session XII - What Is the Incremental Benefit of Additional Tools

11:10 – 11:20
Vascular Closure Devices for EP Procedures – Clinical and Cost Effectiveness Data

11:20 – 11:30
Esophageal Temperature Monitoring – Stethoscope, Circa, Infrared, or Single Tip Thermocouple Probe?

11:30 – 11:40
Safety and Efficacy of Esophageal Deviation During AF Ablation

11:40 – 11:50
RF Transseptal Needle in EP and Structural Procedures

11:50 – 12:00
Leadless Pacemaker Compared to a Single Chamber Transvenous VVI Pacemaker

12:00 – 12:20
Panel Discussion

12:20 – 12:30
Adjourn

KCHRS 2021

Date

August  21-22, 2021
Overland Park Convention Center

Venue

In-Person/Virtual

Register

Registration Coming Soon!